Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value: $324M (100.0% shares, 0.0% debt)

Holdings (14)

GOSS Gossamer Bio 34.0%

Value $110M Shares 6,553,116 Est. Cost $20.85 Unrealized -4.6%

REPL Replimune Group 21.8%

Value $70.69M Shares 5,103,455 Est. Cost $17.53 Unrealized -30.0%

— Morphic Holding 16.6%

Value $53.78M Shares 2,969,582 Est. Cost $19.82 Unrealized —

— Translate Bio 7.5%

Value $24.16M Shares 2,437,603 Est. Cost $12.65 Unrealized —

IMUX Immunic 4.2%

Value $13.71M Shares 1,371,494 Est. Cost $13.14 Unrealized +1.9%

— Paratek Pharmaceuticals 3.5%

Value $11.23M Shares 2,600,410 Est. Cost $34.18 Unrealized —

— ObsEva 2.6%

Value $8.325M Shares 999,364 Est. Cost $9.76 Unrealized —

— Prevail Therapeutics 2.5%

Value $8.214M Shares 668,908 Est. Cost $13.20 Unrealized —

— ESSA Pharma 1.8%

Value $5.762M Shares 1,709,848 Est. Cost $3.14 Unrealized —

TRVI Trevi Therapeutics 1.8%

Value $5.685M Shares 1,263,408 Est. Cost $8.61 Unrealized -36.9%

— FibroGen 1.5%

Value $4.831M Shares 130,646 Est. Cost $27.34 Unrealized —

— Cidara Therapeutics 1.0%

Value $3.273M Shares 1,640,514 Est. Cost $6.35 Unrealized —

— Pieris Pharmaceuticals 0.8%

Value $2.56M Shares 750,741 Est. Cost $1.83 Unrealized —

— Jounce Therapeutics 0.5%

Value $1.765M Shares 529,965 Est. Cost $21.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GOSS	Gossamer Bio	6,553,116	$110M	34.0%	$20.85	-4.6%	Common Stock	38341P102
REPL	Replimune Group	5,103,455	$70.69M	21.8%	$17.53	-30.0%	Common Stock	76029N106
—	Morphic Holding	2,969,582	$53.78M	16.6%	$19.82	—	Common Stock	61775R105
—	Translate Bio	2,437,603	$24.16M	7.5%	$12.65	—	Common Stock	89374L104
IMUX	Immunic	1,371,494	$13.71M	4.2%	$13.14	+1.9%	Common Stock	4525EP101
—	Paratek Pharmaceuticals	2,600,410	$11.23M	3.5%	$34.18	—	Common Stock	699374302
—	ObsEva	999,364	$8.325M	2.6%	$9.76	—	Common Stock	H5861P103
—	Prevail Therapeutics	668,908	$8.214M	2.5%	$13.20	—	Common Stock	74140Y101
—	ESSA Pharma	1,709,848	$5.762M	1.8%	$3.14	—	Common Stock	29668H708
TRVI	Trevi Therapeutics	1,263,408	$5.685M	1.8%	$8.61	-36.9%	Common Stock	89532M101
—	FibroGen	130,646	$4.831M	1.5%	$27.34	—	Common Stock	31572Q808
—	Cidara Therapeutics	1,640,514	$3.273M	1.0%	$6.35	—	Common Stock	171757107
—	Pieris Pharmaceuticals	750,741	$2.56M	0.8%	$1.83	—	Common Stock	720795103
—	Jounce Therapeutics	529,965	$1.765M	0.5%	$21.99	—	Common Stock	481116101